Evidence map›Paper›PMID 25946071›Full record

ArticlePloS one2015

Pandemic Swine-Origin H1N1 Influenza Virus Replicates to Higher Levels and Induces More Fever and Acute Inflammatory Cytokines in Cynomolgus versus Rhesus Monkeys and Can Replicate in Common Marmosets.

Petra Mooij, Gerrit Koopman, Daniëlla Mortier, Melanie van Heteren, Herman Oostermeijer, Zahra Fagrouch, Rudy de Laat, Gary Kobinger, Yan Li, Edmond J Remarque and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Petra MooijDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Gerrit KoopmanDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Daniëlla MortierDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Melanie van HeterenDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Herman OostermeijerDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Zahra FagrouchDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Rudy de LaatDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Gary KobingerNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Yan LiNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Edmond J RemarqueDepartment of Parasitology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Ivanela KondovaAnimal Science Department, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Ernst J VerschoorDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Willy M J M BogersDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Biomedical Primate Research Centre · NLPublic Health Agency of Canada · CA

Funding

Development of a Universal Influenza Seasonal VaccineR01AI092843 · NIAID · WISTAR INSTITUTE · PI WEINER, DAVID B. · 2010 to 2014
$3.0M
NIAID NIH HHS R01 AI092843
6 · The paper itself

Abstract

The close immunological and physiological resemblance with humans makes non-human primates a valuable model for studying influenza virus pathogenesis and immunity and vaccine efficacy against infection. Although both cynomolgus and rhesus macaques are frequently used in influenza virus research, a direct comparison of susceptibility to infection and disease has not yet been performed. In the current study a head-to-head comparison was made between these species, by using a recently described swine-origin pandemic H1N1 strain, A/Mexico/InDRE4487/2009. In comparison to rhesus macaques, cynomolgus macaques developed significantly higher levels of virus replication in the upper airways and in the lungs, involving both peak level and duration of virus production, as well as higher increases in body temperature. In contrast, clinical symptoms, including respiratory distress, were more easily observed in rhesus macaques. Expression of sialyl-α-2,6-Gal saccharides, the main receptor for human influenza A viruses, was 50 to 73 times more abundant in trachea and bronchus of cynomolgus macaques relative to rhesus macaques. The study also shows that common marmosets, a New World non-human primate species, are susceptible to infection with pandemic H1N1. The study results favor the cynomolgus macaque as model for pandemic H1N1 influenza virus research because of the more uniform and high levels of virus replication, as well as temperature increases, which may be due to a more abundant expression of the main human influenza virus receptor in the trachea and bronchi.

Indexed as

AnimalsCallithrixChemokinesCytokinesDisease Models, AnimalFeverHost-Pathogen InteractionsHost SpecificityHumansInflammation MediatorsInfluenza A Virus, H1N1 SubtypeInfluenza, HumanLungMacaca fascicularisMacaca mulattaMaleChemokinesCytokinesInflammation MediatorsReceptors, Virus

Identifiers

PMID25946071
PMCPMC4422689
OpenAlexW338592559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.